Brandan Hillerich, Ph.D., MBA

Brandan Hillerich has served as Vice President of Corporate Development and Strategy since July 2018 and joined Cue Biopharma in January 2017 as Senior Director of Corporate Development. Before joining Cue Biopharma, he worked with the Pharmaceutical and Life Sciences R&D Advisory Team at PricewaterhouseCoopers developing and implementing strategies to support research and development operations across multiple therapeutic areas at top tier pharmaceutical companies. Prior to joining PricewaterhouseCoopers, Dr. Hillerich was a Managing Director for the Macromolecular Therapeutics Development Facility (MTDF) at the Albert Einstein College of Medicine, where he managed a high-throughput pipeline for protein production and was a contributing member of the team that developed the initial technology leading to Cue Biopharma’s Immuno-STAT™ platform. Dr. Hillerich earned an MBA at the Samuel Curtis Johnson Graduate School of Management at Cornell University and received a Ph.D. in Molecular Genetics from the University of Georgia, and a B.S in Biology from the University of Louisville.

« Go Back